LifeMD (NASDAQ:LFMD – Free Report) had its price objective cut by KeyCorp from $10.00 to $7.00 in a report released on Wednesday morning,Benzinga reports. They currently have an overweight rating on ...
Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...